Syngene International has acquired its first manufacturing facility in the US for $36.5 million, while Sunsure Energy is seeking Rs 5000 crore this year to support its expansion plans.
Syngene International buys US manufacturing site
Global contract research, development, and manufacturing organisation Syngene International has acquired its first manufacturing facility in the US from Emergent Manufacturing Operations Baltimore LLC for $36.5 million, according to a release.
The new site is expected to increase Syngene’s total single-use bioreactor capacity to 50,000L for large molecule discovery, development, and manufacturing services. It will expand the company’s global footprint to cater to both human and animal health market segments.
The sale is expected to close by March this year. Located near key biotech hubs in the Northeast of the US, the facility will be operational for client projects from the second half of 2025.
Sunsure Energy seeks $573m debt
Gurugram-based renewable energy company Sunsure Energy is in discussions with investors to raise Rs 5,000 crore ($573 million) in debt this year to support its renewable energy expansion ambitions, according to a report by the ET.
The company, which currently operates around 500 MW, has planned to add 2.5 GW capacity by mid-2027. The capacity expansion will require Rs 9000-10,000 crore in a mix of debt and equity.
Partners Group has committed $400 million (Rs 3,400 crore) in equity to Sunsure Energy. The firm now aims to raise Rs 10,000 crore in debt over the next two years, of which it has already received around Rs 1,000 crore from financiers, including the Aditya Birla Group and Tata Cleantech Capital.
